Zuellig Pharma Corporation, through its commercialization arm ZP Therapeutics, said pharmaceutical firms are expected to heavily invest in their market access capabilities to accelerate vaccine access in the Philippines. Jeff Folland, Philippines general manager of ZP Therapeutics Pharmaceutical of
Healthcare services provider Zuellig Pharma Corp. is expanding its facilities and beefing up its digital solutions in the country to serve increasing demand.
Moderna’s Covid-19 vaccine Spikevax was recently approved by the Food and Drug Administration (FDA) to be used for children six to 11 years old in the country.
FDA Recently, the FDA amended the emergency use authorization (EUA) filed by Zuellig Pharma Corporation, through its commercialization a